メラノサイトの主調節体MitfによるBcl2の調節は,系統生存率とメラノーマ細胞の生存率を調節する
Gaël G McGill1, Martin Horstmann, Hans R Widlund
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Cell
|June 28, 2002
まとめ
マイクロフタルミア関連転写因子 (Mitf) は,メラノサイトの生存に不可欠な遺伝子であるBCL2を調節する. この Mitf-BCL2 接続は,メラノサイトの発達とメラノーマの治療抵抗性にとって不可欠です.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- 細胞生物学 細胞生物学
背景:
- キット/SCFシグナル伝達とMitf依存トランスクリプションは,メラノ細胞の発達と色素化に不可欠です.
- Mitfは,メラノサイト特異遺伝子を調節する重要な転写因子です.
研究 の 目的:
- プライマリメラノサイトにおけるMitf依存の転写標的を特定する.
- メラノサイトとメラノーマにおけるMitfとBCL2の機能的関係を調査する.
主な方法:
- マイクロアレイ分析で,MITFの標的を特定する.
- プロモーター結合を検証するためのクロマチンの免疫プレシピテーション.
- 遺伝的障害 (MitfとBcl2) を有するマウスモデルの分析.
- ヒトのメラノーマ発現データに関する調査.
主要な成果:
- BCL2は,Mitf依存の転写標的として特定されました.
- Mitfは,メラノサイト,メラノーマ細胞,骨格細胞におけるBCL2発現を直接調節する.
- MitfまたはBCL2が欠けているマウスは,骨粗鬆症を発症します.
- Mitfの破壊はメラノサイトとメラノーマのアポトーシスを誘発し,BCL2によって救出することができます.
- MITFとBCL2は,ヒトメラノーマにおける相関表現を示しています.
結論:
- MitfとBCL2は,メラノサイト系統の生存において,連携的な役割を果たします.
- Mitf-BCL2 調節軸は,メラノ細胞の発達と色素化に不可欠です.
- このリンクは,メラノーマの治療抵抗性についての洞察を提供します.
関連する概念動画
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...